As a research compound, AOD9604 UK carries a well-characterised pre-clinical and early-phase clinical research profile developed primarily through the work of Metabolic Pharmaceuticals, with published studies spanning lipid metabolism, adipose biology, 3-adrenergic receptor regulation, cartilage biology, and safety pharmacology
burned a bit at first but got used to it
Methionine, inositol, and choline are legitimately involved in hepatic lipid handling
Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin and Visceral Adiposity Research studies have observed a reduction in visceral adiposity in test models exposed to Tesamorelin
Compounded drugs are not directly approved by the FDA in the same way as commercial drugs
A provider factors these in before adding B12, NAD, or lipotropic injections